Decision · Objection under Rule 112(2) and (3), and (4)(c)

Maximum residue levels for thiacloprid

Effect: Objection passed
Result: 386 for · 186 against · 52 abstained roll call
Date: 17 January 2024, 12:18
Kind: Objection to a Commission measure

More facts (8)

Margin: by a clear majority
Counts are for: the objection
Text: Motion B-9-2024-0057
Source: Motion for a resolution
Votes: 1 vote · 1 roll call
Requested by: The Left (1 roll call)
Sitting: Wednesday 17 January 2024
Final vote: 163315

Margin: by a clear majority
Counts are for: the objection
Text: Motion B-9-2024-0057
Source: Motion for a resolution
Votes: 1 vote · 1 roll call
Requested by: The Left (1 roll call)
Sitting: Wednesday 17 January 2024
Final vote: 163315

Cite this page Roll-call results (EP)

Link to this page

Votes on this decision

Members on the final vote

Result

The final vote and what it means for this kind of decision.

Objection passed by a clear majority.

The objection passed, so the Commission measure cannot enter into force.

Backed by The Left, Greens, S&D, Renew and Patriots; opposed by EPP; ECR and ESN mostly abstained.

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
Group	For	Against	Abst.	Majority line	Clear line
The Left	For 13	Against 0	Abst. 0	Majority line For	Clear line For
Greens	For 25	Against 0	Abst. 0	Majority line For	Clear line For
S&D	For 61	Against 0	Abst. 0	Majority line For	Clear line For
Renew	For 26	Against 13	Abst. 0	Majority line For	Clear line For
EPP	For 22	Against 60	Abst. 4	Majority line Against	Clear line Against
ECR	For 3	Against 10	Abst. 12	Majority line Abstained	Clear line Divided
Patriots	For 17	Against 7	Abst. 5	Majority line For	Clear line Divided
ESN	For 1	Against 0	Abst. 3	Majority line Abstained	Clear line Abstained
No group	For 6	Against 0	Abst. 0	Majority line For	Clear line For

Voted against their group, 0

Members who voted otherwise than a clear line (at least two thirds of the votes cast) of their group — groups as of today: the view with groups at the date of the vote is not available right now.

Nobody voted against a clear line of their group.

Countries

The final vote by national delegation.

The breakdown by country is not available right now.

Members

Each member’s recorded position on the final roll call — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 624 members

All votes on this decision, 1

In voting order. **Result**: for–against–abstained (a show of hands has no count). **Requested by**: the groups that asked for a roll call, a split vote or a separate vote.
No.	Vote	Recorded	Result	Requested by
1	Final vote on the motion for a resolution B9-0057/2024 – Motion for a resolution	Roll call	386 for, 186 against, 52 abstained Adopted	Requested byroll call: The Left

Roll call requested by The Left.

Text

The text voted on.

Motion B-9-2024-0057

Connections

What this decision touches: the procedural chain, the same text, running issues, votes that split the chamber the same way.

No connections found for this decision.

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/decisions/2024-01-17/5
Official sources: Roll-call votes, sitting of 17 January 2024 (European Parliament)
Results of votes, sitting of 17 January 2024 (European Parliament)
Data source: EP Open Data API: decisions of the sitting MTG-PL-2024-01-17
Licensed CC BY 4.0.
Retrieved: 25 September 2026

Cite as

European Parliament (2024). “Maximum residue levels for thiacloprid”. Decision, 17 January 2024. votingId 163315, document B-9-2024-0057. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/decisions/2024-01-17/5 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 17 January 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-01-17-RCV_EN.html; Results of votes, sitting of 17 January 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-01-17-VOT_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-01-17, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-01-17/decisions?format=application%2Fld%2Bjson (CC BY 4.0).

BibTeX

@misc{epw-decision-2024-01-17-5,
  author = {{European Parliament}},
  title = {{Maximum residue levels for thiacloprid}},
  year = {2024},
  date = {2024-01-17},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/decisions/2024-01-17/5}},
  url = {https://news.eu-parl.st-solutions.dev/decisions/2024-01-17/5},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Decision. votingId 163315, document B-9-2024-0057. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-01-17-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-01-17-VOT\_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-01-17 (CC BY 4.0)}
}